Loading
Latest filing published 17 Jun 2026 for Aprea Therapeutics, Inc..
No signal scores available.
All filings by Gabriela Gruia on record concern Aprea Therapeutics, Inc. The record holds 2 filings, for trades running from 5 June 2025 to 16 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 17 June 2026, reports a share grant in Aprea Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations